BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 35157210)

  • 41. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
    Hrenak J; Zorad S; Simko F
    Gen Physiol Biophys; 2020 May; 39(3):203-204. PubMed ID: 32525813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The endocrine system function disturbances during and after SARS-CoV-2 infection.
    Ogarek N; Oboza P; Olszanecka-Glinianowicz M; Kocelak P
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2171-2178. PubMed ID: 35363367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
    Hooper NM; Lambert DW; Turner AJ
    Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 45. Endocrine Significance of SARS-CoV-2's Reliance on ACE2.
    Lazartigues E; Qadir MMF; Mauvais-Jarvis F
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32652001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of ACE2 autoantibodies after SARS-CoV-2 infection.
    Arthur JM; Forrest JC; Boehme KW; Kennedy JL; Owens S; Herzog C; Liu J; Harville TO
    PLoS One; 2021; 16(9):e0257016. PubMed ID: 34478478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin-angiotensin-aldosterone system and COVID-19 infection.
    Alexandre J; Cracowski JL; Richard V; Bouhanick B;
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.
    Zamai L
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
    Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
    Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
    Cano F; Gajardo M; Freundlich M
    Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later.
    Angeli F; Zappa M; Reboldi G; Trapasso M; Cavallini C; Spanevello A; Verdecchia P
    Eur J Intern Med; 2021 Nov; 93():28-34. PubMed ID: 34588140
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential role of the carotid body in COVID-19.
    Porzionato A; Emmi A; Stocco E; Barbon S; Boscolo-Berto R; Macchi V; De Caro R
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L620-L626. PubMed ID: 32755325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19.
    Lanza K; Dias R; Dos Santos Oliveira RM; Belotto L; Miranda AS; Simões E Silva AC
    Curr Med Chem; 2021; 28(28):5733-5787. PubMed ID: 33583366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.
    Engin AB; Engin ED; Engin A
    Environ Toxicol Pharmacol; 2020 Aug; 78():103411. PubMed ID: 32422280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms.
    Song Y; Fan H; Tang X; Luo Y; Liu P; Chen Y
    Int J Neurosci; 2023 Feb; 133(2):176-185. PubMed ID: 33653215
    [No Abstract]   [Full Text] [Related]  

  • 60. The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic.
    Sehn F; Büttner H; Godau B; Müller M; Sarcan S; Offermann A; Perner S; Kramer MW; Merseburger AS; Roesch MC
    Mol Biol Rep; 2023 Feb; 50(2):1809-1816. PubMed ID: 36478297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.